Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial

Sue Ross, Magali Robert, Doug Lier, Misha Eliasziw, Philip Jacobs, Sue Ross, Magali Robert, Doug Lier, Misha Eliasziw, Philip Jacobs

Abstract

Background: We recently completed a randomized clinical trial of two minimally invasive surgical procedures for stress urinary incontinence, the retropubic tension-free vaginal tape (TVT) versus the trans-obturator tape (TOT) procedure. At one year postoperatively, we were concerned to find that a significant number of women had tape that was palpable when a vaginal examination was undertaken. Because the risk factors for adverse outcomes of tape surgery are not clearly understood, we are unable to say whether palpable tapes will lead to vaginal erosions or whether they merge into vaginal tissue. We do not know whether patients go on to have further adverse consequences of surgery, leading to additional cost to patients and healthcare system. Our current study is a 5 year follow-up of the women who took part in our original trial.

Methods/design: All 199 women who participated in our original trial will be contacted and invited to take part in the follow-up study. Consenting women will attend a clinic visit where they will have a physical examination to identify vaginal erosion or other serious adverse outcomes of surgery, undertake a standardized pad test for urinary incontinence, and complete several health-related quality of life questionnaires (15D, UDI-6, IIQ-7). Analyses will compare the outcomes for women in the TOT versus TVT groups. The cost-effectiveness of TOT versus TVT over the 5 years after surgery, will be assessed with the use of disease-specific health service administrative data and an objective health outcome measure. A cost-utility analysis may also be undertaken, based on economic modeling, data from the clinical trial and inputs obtained from published literature.

Discussion: This study is needed now, because TOT and TVT are among the most frequently conducted surgical procedures for stress urinary incontinence in Canada. Because stress urinary incontinence is so common, the impact of selecting an approach that causes more adverse events, or is less effective, will have a significant impact on individual quality of life, and societal and health care costs.

Trial registration: ClinicalTrials.gov NCT00234754. Registered October 2005.

Figures

Figure 1
Figure 1
Illustrative Markov model structure [53].

References

    1. Health Canada Marketed Health Products Directorate. Complications associated with transvaginal implantation of surgical mesh for the treatment of stress urinary incontinence and pelvic organ prolapse (4 February 2010) (accessed 6 July 2011)
    1. FDA Public Health Notification. Serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence (October 20, 2008) (accessed 6 July 2011)
    1. Minassian V, Drutz H, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Obstet Gynecol. 2002;82:327–338.
    1. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278–83. doi: 10.1097/AOG.0b013e3181c2ce96.
    1. Milsom I. Lower urinary tract symptoms in women. Curr Opin Urol. 2009;19(4):337–41. doi: 10.1097/MOU.0b013e32832b659d.
    1. Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gyecol. 2001;184:1496–503. doi: 10.1067/mob.2001.114868.
    1. Ross S, Robert M, Harvey MA, Farrell S, Schulz J, Wilkie D, Lovatsis D, Epp A, Easton B, McMillan B, Schachter J, Gupta C, Weijer C. Ethical issues associated with the introduction of new surgical devices: or just because we can doesn't mean we should. J Obstet Gynaecol Can. 2008;30(6):508–513.
    1. Norton P. New technology in gynaecologic surgery: is new necessarily better? Am J Obstet Gynecol. 2006;108:707–8. doi: 10.1097/01.AOG.0000236129.96833.50.
    1. Ostergard DR. Lessons from the past: directions for the future. Do new marketed surgical procedures and grafts produce ethical, personal liability, and legal concerns for physicians? Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(6):591–8. doi: 10.1007/s00192-007-0330-z.
    1. Department of Justice Canada. Food and Drugs Act, Medical Devices Regulations (SOR/98-282) (accessed 6 July 2011)
    1. Health Canada. Recognition and Use of Standards under the Medical Devices Regulations. (accessed 6 July 2011)
    1. Lenzer J. Watching over the medical device industry. BMJ. 2009;338:b2321. doi: 10.1136/bmj.b2321.
    1. Eaton ML, Kennedy D. In: Innovation in medical technology--ethical issues and challenges. Eaton ML, Kennedy D, editor. Baltimore: John Hopkins University Press; 2007. The need to ask questions about innovation; pp. 1–22.
    1. Eaton ML, Kennedy D. In: Innovation in medical technology - ethical issues and challenges. Eaton ML, Kennedy D, editor. Baltimore: John Hopkins University Press; 2007. Innovative surgery; pp. 57–71.
    1. Ross S, Grant A, Gillespie W, Counsel C, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epi. 1999;52:1143–1156. doi: 10.1016/S0895-4356(99)00141-9.
    1. Ross S, Robert M, Swaby C, Dederer L, Lier D, Tang S, Brasher P, Birch C, Cenaiko D, Mainprize T, Murphy M, Carlson K, Baverstock R, Jacobs P, Williamson T. Transobturator tape compared with tension-free vaginal tape for stress incontinence. A randomized controlled trial. Obstet Gynecol. 2009;114(6):1287–1294. doi: 10.1097/AOG.0b013e3181c2a151.
    1. Stach-Lempinen B, Sintonen H, Kujansuu E. The relationship between clinical parameters and health - related quality of life as measured by the 15D in incontinent women before and after treatment. Acta Obst Gynecol Scand. 2004;83:983–988.
    1. Nygaard I, Girts T, Fultz N, Kinchen K, Pohl G, Sternfeld B. Is urinary incontinence a barrier to exercise in women? Obstet Gynecol. 2005;106:307–314. doi: 10.1097/01.AOG.0000168455.39156.0f.
    1. Papanicolaou S, Hunskaar S, Lose G, Sykes D. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain, and the UK. BJU Int. 2005;96:831–838. doi: 10.1111/j.1464-410X.2005.05722.x.
    1. Oh SJ, Ku J, Choo MS, Yun J, Kim D, Park WH. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol. 2008;15:62–67. doi: 10.1111/j.1442-2042.2007.01905.x.
    1. Thom D, Haan M, Van den Eeden S. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission, and mortality. Age Ageing. 1997;26:367–374. doi: 10.1093/ageing/26.5.367.
    1. Chu L, Pei C. Risk factors for early hospital readmission in elderly medical patients. Gerontology. 1999;45:220–226. doi: 10.1159/000022091.
    1. Wagner T, Hu T. Economic costs of urinary incontinence in 1995. Urology. 1998;51:355–361. doi: 10.1016/S0090-4295(97)00623-7.
    1. Kinchen KS, Long S, Orsini L, Crown W, Swindle R. A retrospective claims analysis of the direct costs of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(6):403–11. doi: 10.1007/s00192-003-1096-6.
    1. The Canadian Continence Foundation. Incontinence: A Canadian Perspective. (accessed 6 July 2011)
    1. Hannestad Y, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT study. J Clin Epidemiol. 2000;53:1150–1157. doi: 10.1016/S0895-4356(00)00232-8.
    1. Minassian VA, Stewart WF, Wood GC. Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol. 2008;111(2 Pt 1):324–31.
    1. Keane D, O'Sullivan S. Urinary incontinence: anatomy, physiology, and pathophysiology. Best Pract Res Clin Obstet Gynaecol. 2000;14:207–226. doi: 10.1053/beog.1999.0072.
    1. Allen-Brady K, Norton PA, Farnham JM, Teerlink C, Cannon-Albright LA. Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet. 2009;84(5):678–82. doi: 10.1016/j.ajhg.2009.04.002.
    1. Sampselle C. Behavioral interventions in young and middle-aged women. Am J Nurs. 2003;3(suppl):9–14.
    1. Milne JL, Robert M, Tang S, Drummond N, Ross S. Goal achievement as a patient-generated outcome measure for stress urinary incontinence. Health Expect. 2009;12(3):288–300. doi: 10.1111/j.1369-7625.2009.00536.x.
    1. Waetjen L, Subak L, Hui S, Feng L, Tsung-His W, Vittinghoff E, Brown J. Stress urinary incontinence surgery in the United States. Obstet Gynecol. 2003;101:671–676. doi: 10.1016/S0029-7844(02)03124-1.
    1. Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7:81–85. doi: 10.1007/BF01902378.
    1. Ward KL, Hilton P, Browning J. for UK & Ireland TVT trial group. Prospective multicentre randomized trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ. 2002;325:67. doi: 10.1136/bmj.325.7355.67.
    1. Valpas A, Kivela A, Penttinen J, Kauko M, Kujansuu E, Tomas E, Haarala M, Meltomaa S, Nilsson CK. Tension-free vaginal tape and laparoscopic mesh colposuspension in the treatment of stress urinary incontinence: immediate outcome and complications - a randomized clinical trial. Acta Obstet Gynecol Scand. 2003;82:665–71.
    1. Cody J, Wyness L, Wallace S, Glazener C, Kilonzo M, Stearns S, McCormack K, Vale L, Grant A. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. Health Technol Assess. 2003;7(iii):1–189.
    1. Karram MM, Segal JL, Vassallo BJ, Kleeman SD. Complications and untoward effects of the tension-free vaginal tape procedure. Obstet Gynecol. 2003;101:929–32. doi: 10.1016/S0029-7844(03)00122-4.
    1. Al-Badr A, Ross S, Soroka D, Minassian VA, Karahalios A, Drutz HP. Voiding patterns and urodynamics after a tension-free vaginal tape procedure. J Obstet Gynaecol Can. 2003;25:725–30.
    1. Amna MB, Randrianantenaina A, Michel F. Colic perforation as a complication of tension-free vaginal tape procedure. J Urol. 2003;170:2387. doi: 10.1097/01.ju.0000095806.94090.14.
    1. Zilbert AW, Farrell SA. External iliac artery laceration during tension-free vaginal tape procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12:141–143. doi: 10.1007/s001920170081.
    1. Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008;180:1890–7. doi: 10.1016/j.juro.2008.07.029.
    1. Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol. 2001;11:1306–1313.
    1. Dobson A, Robert M, Swaby C, Murphy M, Birch C, Mainprize T, Ross S. Trans-obturator surgery for stress urinary incontinence: one year follow-up of a cohort of 52 women. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:27–32. doi: 10.1007/s00192-006-0115-9.
    1. Cosson M, Debodinance P, Boukerrou M, Chauvet MP, Lobry P, Crepin G, Ego A. Mechanical properties of synthetic implants used in the repair of prolapse and urinary incontinence in women: which is the ideal material? Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:169–78. doi: 10.1007/s00192-003-1066-z.
    1. Lier D, Ross S, Tang S, Robert M, Jacobs P. for the Calgary Women's Pelvic Health Research Group. A cost utility analysis of trans-obturator tape compared with tension-free vaginal tape in the surgical treatment of stress urinary incontinence. BJOG. 2011;118(5):550–556. doi: 10.1111/j.1471-0528.2010.02845.x.
    1. Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009. p. CD006375.
    1. Sung VW, Schleinitz MD, Rardin CR, Ward RM, Myers DL. Comparison of retropubic vs transobturator approach to midurethral slings: a systematic review and meta-analysis. Am J Obstet Gynecol. 2007;197:3–11. doi: 10.1016/j.ajog.2006.09.025.
    1. Novara G, Galfano A, Boscolo-Berto R, Secco S, Cavalleri S, Ficarra V, Artibani W. Complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices. Eur Urol. 2008;53(2):288–308. doi: 10.1016/j.eururo.2007.10.073.
    1. Latthe P, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007;114:522–531. doi: 10.1111/j.1471-0528.2007.01268.x.
    1. Long CY, Hsu CS, Wu MP, Liu CM, Wang TN, Tsai EM. Comparison of tension-free vaginal tape and transobturator tape procedure for the treatment of stress urinary incontinence. Curr Opin Obst Gynecol. 2009;21:342–347. doi: 10.1097/GCO.0b013e32832e07bf.
    1. Novara G, Ficarra V, Boscolo-Berto R, Secco S, Cavalleri S, Artibani W. Tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials of effectiveness. Eur Urol. 2007;52:663–679. doi: 10.1016/j.eururo.2007.06.018.
    1. Manca A, Sculpher MJ, Ward K, Hilton P. A cost-utility analysis of tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence. BJOG. 2003;110(3):255–62.
    1. Wu JM, Visco AG, Weidner AC, Myers ER. Is Burch colposuspension ever cost-effective compared with tension-free vaginal tape for stress incontinence? Am J Obstet Gynecol. 2007;197(1):62.e1–5. doi: 10.1016/j.ajog.2007.02.039.
    1. Kilonzo M, Vale L, Stearns SC, Grant A, Cody J, Glazener CM, Wallace S, McCormack K. Cost effectiveness of tension-free vaginal tape for the surgical management of female stress incontinence. Int J Technol Assess Health Care. 2004;20(4):455–63.
    1. Castillón Vela IT, Redondo González E, Linares Quevedo AI, Vallejo Herrador J, Ríos González E, Sáenz Medina J, Páez Borda A. Outpatient female stress urinary incontinence surgery: budget impact study. Arch Esp Urol. 2007;60(3):267–72.
    1. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. for the CONSORT and Pragmatic Trials in Healthcare (Practihc) groups. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390. doi: 10.1136/bmj.a2390.
    1. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardization of terminology of lower urinary tract function recommended by the International Continence Society. Int Urogynecol J. 1990;1:45–58. doi: 10.1007/BF00373608.
    1. Farrell SA, Epp A, Flood C, Lajoie F, MacMillan B, Mainprize T, Robert M. The evaluation of stress incontinence prior to primary surgery: SOGC clinical practice guidelines. J Obstet Gynaecol Can. 2003;25:313–24.
    1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline, E2D. Post-approval safety data management: definitions and standards for expedited reporting. (accessed 6 July 2011)
    1. Soroka D, Drutz HP, Glazener CM, Hay-Smith EJ, Ross S. Perineal pad test in evaluating outcome of treatments for female incontinence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(3):165–75. doi: 10.1007/s192-002-8348-z.
    1. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14:131–39. doi: 10.1002/nau.1930140206.
    1. FitzGerald MP, Kenton K, Shott S, Brubaker L. Responsiveness of quality of life measurements to change after reconstructive pelvic surgery. Am J Obstet Gynecol. 2001;185:20–24. doi: 10.1067/mob.2001.116364.
    1. Robinson D, Pearce KF, Preisser JS, Dugan E, Suggs PK, Cohen SJ. Relationship between patient reports of urinary incontinence symptoms and quality of life measures. Obstet Gynecol. 1998;91:224–28. doi: 10.1016/S0029-7844(97)00627-3.
    1. Harvey MA, Kristjansson B, Griffith D, Versi E. The Incontinence Impact Questionnaire and the Urogenital Distress Inventory: a revisit of their validity in women without urodynamic diagnosis. Am J Obstet Gynecol. 2001;185:25–31. doi: 10.1067/mob.2001.116369.
    1. Ross S, Soroka D, Karahalios A, Glazener CMA, Hay-Smith EJC, Drutz HP. Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(3):272–285. doi: 10.1007/s00192-005-1357-7.
    1. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328–36. doi: 10.3109/07853890109002086.
    1. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. Third. Oxford: Oxford University Press; 2005.
    1. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487–96. doi: 10.1002/hec.944.
    1. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300(6719):230–5. doi: 10.1136/bmj.300.6719.230.
    1. Shields L, Pearn J. Inducements for medical and health research: issues for the profession of nursing. J Clin Nurs. 2007;16(7):1196–200. doi: 10.1111/j.1365-2702.2007.01889.x.
    1. Ulrich CM, Danis M, Koziol D, Garrett-Mayer E, Hubbard R, Grady C. Does it pay to pay? A randomized trial of prepaid financial incentives and lottery incentives in surveys of nonphysician healthcare professionals. Nurs Res. 2005;54(3):178–83.
    1. Grady C, Dickert N, Jawetz T, Gensler G, Emanuel E. An analysis of U.S. practices of paying research participants. Contemp Clin Trials. 2005;26(3):365–75. doi: 10.1016/j.cct.2005.02.003.
    1. Sears JM. The payment of research subjects: ethical concerns. Oncol Nurs Forum. 2001;28(4):657–63.
    1. Dickert N, Emanuel E, Grady C. Paying research subjects: an analysis of current policies. Ann Intern Med. 2002;136(5):368–73.
    1. Canadian Institutes for Health Information. Canadian Coding Standards for ICD-10-CA and CCI, 2009. (accessed 6 July 2011)
    1. Guidelines for the economic evaluation of health technologies: Canada. 3. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe